apo-meloxicam
arrotex pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - capsule - excipient ingredients: titanium dioxide; sunset yellow fcf; magnesium stearate; maize starch; sodium citrate dihydrate; gelatin; lactose monohydrate; brilliant blue fcf; quinoline yellow - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.
apo-meloxicam
arrotex pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - capsule - excipient ingredients: titanium dioxide; lactose monohydrate; gelatin; sodium citrate dihydrate; maize starch; brilliant blue fcf; magnesium stearate; sunset yellow fcf - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.
meloxicam- meloxicam tablet meloxicam- meloxicam tablet
rebel distributors corp. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 7.5 mg - carefully consider the potential benefits and risks of meloxicam and other treatment options before deciding to use meloxicam. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). meloxicam is indicated for relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis. meloxicam is contraindicated in patients with known hypersensitivity to meloxicam. meloxicam should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings , anaphylactoid reactions , and precautions , pre-existing asthma ). meloxicam is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ).
meloxicam-dp meloxicam 15mg tablet blister pack
medis pharma pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; maize starch; sodium citrate dihydrate; colloidal anhydrous silica; magnesium stearate - meloxicam-dp is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.
meloxicam-dp meloxicam 7.5 mg tablet blister pack
medis pharma pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; maize starch; sodium citrate dihydrate; colloidal anhydrous silica; magnesium stearate - meloxicam-dp is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.
meloxicam sandoz meloxicam 15 mg capsule blister pack
sandoz pty ltd - meloxicam, quantity: 15 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; sodium citrate dihydrate; magnesium stearate; gelatin; titanium dioxide; sunset yellow fcf; brilliant blue fcf; quinoline yellow - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.
meloxicam sandoz meloxicam 7.5 mg capsule blister pack
sandoz pty ltd - meloxicam, quantity: 7.5 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; sodium citrate dihydrate; magnesium stearate; gelatin; titanium dioxide; sunset yellow fcf; brilliant blue fcf - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.
apo-meloxicam meloxicam 15mg tablet blister pack
apotex pty ltd - meloxicam -
apo-meloxicam meloxicam 7.5mg tablet blister pack
apotex pty ltd - meloxicam -
meloxicam viatris meloxicam 7.5 mg tablet blister pack
helix pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; sodium citrate dihydrate; colloidal anhydrous silica; crospovidone; microcrystalline cellulose - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.